- Home
- RYTM vs CRUS Comparison
RYTM vs CRUS Comparison
Compare RYTM & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYTM | CRUS |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.9B |
| IPO Year | 2017 | 1989 |
Fundamental Metrics
Financial Performance| Metric | RYTM | CRUS |
|---|---|---|
| Price | $98.07 | $122.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | $128.31 | ★ $140.00 |
| AVG Volume (30 Days) | ★ 967.0K | 428.2K |
| Earning Date | 02-25-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.23 |
| EPS | N/A | ★ 7.02 |
| Revenue | $174,334,000.00 | ★ $1,948,426,000.00 |
| Revenue This Year | $47.34 | $0.95 |
| Revenue Next Year | $55.95 | $1.88 |
| P/E Ratio | ★ N/A | $17.04 |
| Revenue Growth | ★ 54.92 | 2.19 |
| 52 Week Low | $45.91 | $75.83 |
| 52 Week High | $122.20 | $136.92 |
Technical Indicators
Market Signals| Indicator | RYTM | CRUS |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 53.42 |
| Support Level | $97.38 | $115.93 |
| Resistance Level | $103.20 | $123.75 |
| Average True Range (ATR) | 4.20 | 3.14 |
| MACD | -1.61 | 0.11 |
| Stochastic Oscillator | 12.15 | 85.93 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.